21 February 2019
BiomX raises $32M series B to bring first two therapies to clinic
Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday, 20th February, that will take its lead candidate, acne therapy BX001,...